Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Inmune Bio Inc (INMB)
NASDAQ:INMB
Inmune Bio (INMB) Stock Price & Analysis
241 Followers
INMB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.63 - $10.75
Previous Close$6.74
Volume31.89K
Average Volume (3M)56.08K
Market Cap
$120.42M
Enterprise Value$120.42M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-4.4
Beta1.33
Next Earnings
May 18, 2023EPS Estimate
-$0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.52
Shares Outstanding17,945,995
10 Day Avg. Volume48,085
30 Day Avg. Volume56,077
Standard Deviation0.30
R-Squared0.14
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)2.70
Price to Sales (P/S)323.41
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-5.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue434.72
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-5.93
Forecast
1Y Price Target
$18.00Price Target Upside166.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Inmune Bio News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
INMB FAQ
What was Inmune Bio Inc’s price range in the past 12 months?
Inmune Bio Inc lowest stock price was $4.63 and its highest was $10.75 in the past 12 months.
What is Inmune Bio Inc’s market cap?
Currently, no data Available
When is Inmune Bio Inc’s upcoming earnings report date?
Inmune Bio Inc’s upcoming earnings report date is May 18, 2023 which is in 49 days.
How were Inmune Bio Inc’s earnings last quarter?
Inmune Bio Inc released its earnings results on Mar 02, 2023. The company reported -$0.32 earnings per share for the quarter, beating the consensus estimate of -$0.485 by $0.165.
Is Inmune Bio Inc overvalued?
According to Wall Street analysts Inmune Bio Inc’s price is currently Undervalued.
Does Inmune Bio Inc pay dividends?
Inmune Bio Inc does not currently pay dividends.
What is Inmune Bio Inc’s EPS estimate?
Inmune Bio Inc’s EPS estimate is -$0.02.
How many shares outstanding does Inmune Bio Inc have?
Inmune Bio Inc has 17,945,995 shares outstanding.
What happened to Inmune Bio Inc’s price movement after its last earnings report?
Inmune Bio Inc reported an EPS of -$0.32 in its last earnings report, beating expectations of -$0.485. Following the earnings report the stock price went down -7.309%.
Which hedge fund is a major shareholder of Inmune Bio Inc?
Currently, no hedge funds are holding shares in INMB
---
Inmune Bio Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$18.00 (166.67% Upside)
$18.00 (166.67% Upside)
Blogger Sentiment
Bullish
INMB Sentiment 100%
Sector Average 69%
Sector Average 69%
Insider Transactions
Bought Shares
Worth $16.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 0.8%
Last 30 Days ▼ 0.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.35%
12-Months-Change
Fundamentals
Return on Equity
-38.91%
Trailing 12-Months
Asset Growth
-18.16%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Inmune Bio Inc
Inmune Bio, Inc. is a clinical stage biotechnology company, which develops immunotherapies that reprogram a patient's innate immune system to allow the immune system to fight cancer. Its products include INKMUNE and INB03. The company was founded by Mark Lowdell in September 2015 and is headquartered in La Jolla, CA.
---
Top 5 ETFs holding INMB
Fidelity Nasdaq Composite Index ETF
$242.87K
iShares Core S&P Total U.S. Stock Market ETF
$33.50K
Up to five ETFs with an Outperform Smart Score that hold INMB. The ETFs are listed according to market value of INMB within the ETF
---
---